Vương quốc Anh - Tiếng Anh - MHRA (Medicines & Healthcare Products Regulatory Agency)

waymade healthcare plc - alfuzosin hydrochloride - oral tablet - 2.5mg

Vương quốc Anh - Tiếng Anh - MHRA (Medicines & Healthcare Products Regulatory Agency)

milpharm ltd - alfuzosin hydrochloride - oral tablet - 2.5mg

Vương quốc Anh - Tiếng Anh - MHRA (Medicines & Healthcare Products Regulatory Agency)

mawdsley-brooks & company ltd - alfuzosin hydrochloride - oral tablet - 2.5mg

Israel - Tiếng Anh - Ministry of Health

teva israel ltd - alfuzosin hydrochloride - tablets extended release - alfuzosin hydrochloride 10 mg - alfuzosin - treatment of certain functional symptoms of benign prostatic hypertrophy particularly if surgery has to be delayed for some reason. adjuvant treatment to a catheter in acute urinary retention related to benign prostatic hypertrophy.

Ai-len - Tiếng Anh - HPRA (Health Products Regulatory Authority)

rowex ltd - alfuzosin hydrochloride - prolonged-release tablet - 10 milligram(s) - alpha-adrenoreceptor antagonists; alfuzosin

Bỉ - Tiếng Anh - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

sandoz sa-nv - alfuzosin hydrochloride 5 mg - prolonged-release tablet - 5 mg - alfuzosin hydrochloride 5 mg - alfuzosin

Bỉ - Tiếng Anh - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

sandoz sa-nv - alfuzosin hydrochloride 10 mg - prolonged-release tablet - 10 mg - alfuzosin hydrochloride 10 mg - alfuzosin

Hoa Kỳ - Tiếng Anh - NLM (National Library of Medicine)

avera mckennan hospital - alfuzosin hydrochloride (unii: 75046a1xtn) (alfuzosin - unii:90347ytw5f) - alfuzosin hydrochloride 10 mg

Úc - Tiếng Anh - Department of Health (Therapeutic Goods Administration)

gilead sciences pty ltd - tenofovir alafenamide fumarate, quantity: 11.2 mg; emtricitabine, quantity: 200 mg; elvitegravir, quantity: 150 mg; cobicistat, quantity: 150 mg - tablet, film coated - excipient ingredients: croscarmellose sodium; hyprolose; lactose monohydrate; magnesium stearate; sodium lauryl sulfate; microcrystalline cellulose; silicon dioxide; titanium dioxide; purified talc; iron oxide yellow; polyvinyl alcohol; macrogol 3350; indigo carmine aluminium lake - genvoya is indicated as a single tablet regimen for the treatment of hiv-1 infection in adults and paediatric patients weighing at least 25 kg who are either treatment?na?ve; or virologically suppressed (hiv-1 rna <50 copies/ml) on a stable antiretroviral regimen at start of therapy in order to replace their current antiretroviral treatment regimen (see 5.1 pharmacodynamic properties, clinical trials). patients must not have a history of treatment failure or known mutations associated with resistance to the antiretroviral components of genvoya. genvoya is a fixed dose combination of one integrase inhibitor, one pharmacokinetic enhancer and two nucleos(t)ide hiv-1 reverse transcriptase inhibitors.

Canada - Tiếng Anh - Health Canada

pro doc limitee - alfuzosin hydrochloride - tablet (extended-release) - 10mg - alfuzosin hydrochloride 10mg - selective alfa-1-adrenergic blocking agents